Lyka Labs Ltd share price logo

Lyka Labs Ltd

NSE: LYKALABS

BSE: 500259

Small Cap

Pharma Sector

₹79.93

-1.32

(-1.62%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Lyka Labs shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

+9%

Searches for Lyka Labs on INDmoney have increased by 9% over the last 30 days.

Lyka Labs Stock Performance

as on September 16, 2026 at 5:45 pm IST

  • Day's High

    ₹79.93
    ₹80.00

    0.09%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹44.10
    ₹101.90
    downward going graph

    44.83%

    Downside

    27.49%

    Upside

    downward going graph

Lyka Labs share price movements today

Previous Close
₹81.25
Open
₹79.93
Volume
4,707.00
Upper Circuit
₹82.87
Lower Circuit
₹79.63
Day's Low - High
₹79.93 - ₹80.00
52 Week Low - High
₹44.10 - ₹101.90

Lyka Labs Historical Returns

1 Month Return
+ 19.43 %
3 Month Return
+ 17.21 %
1 Year Return
-17.91 %
3 Year Return
-27.33 %
5 Year Return
-6.34 %

Lyka Labs Fundamentals

as on September 16, 2026 at 12:15 pm IST

Market Cap

₹293.74 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

-33.56

Return on capital employed (ROCE)

0

Industry PE ratio

51.81

Beta (LTM)

1.14

P/B Ratio

1.84

Dividend Yield

0

PEG Ratio

7.39

Quarterly Earnings Growth YOY

105

EPS (TTM)

-2.92

Book Value

25.89

Lyka Labs Stock Valuation

as on September 16, 2026 at 12:15 pm IST

Lyka Labs in the last 5 years

  • Overview

  • Trends

Lowest (-419.65x)

January 5, 2026

Today (-33.56x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (178.85x)

October 13, 2025

LowHigh

Today’s Price to Earnings Ratio: -33.56x

Lyka Labs Technical Analysis

Track how Lyka Labs technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish5
Bullish3
Neutral7

Oscillators

Name

Value

Action

MACD level (12,26)
0
Bullish
CCI (20)
-35.09
Neutral
RSI (14)
5.12
Bullish
Momentum (10)
0
Neutral
ADI (14)
94.8
Neutral
Ultimate Oscillator (7,14,28)
0
Bearish

Moving Averages

Name

Value

Action

SMA (20)
79.93
Neutral
EMA (20)
79.93
Bearish
VWMA (20)
79.93
Neutral
SMA (50)
79.93
Neutral
EMA (50)
79.94
Bearish
SMA (200)
80.49
Bearish
EMA (200)
80.37
Bearish
KAMA (200)
79.93
Neutral
DEMA (200)
79.75
Bullish

Lyka Labs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lyka Labs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Lyka Labs Ltd image
Lyka Labs Ltd
NA293.74-1.27%0.68-11128
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA29.1947.69%0.001NA
Concord Biotech Ltd image
Concord Biotech Ltd
BUY15,409.9711.25%0.502591,054
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.7921.54%0.00-121
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD14,671.79-3.06%0.541,3714,078
See all

Lyka Labs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
27.99
32.56
27.77
30.11
41.16
33.8
33.43
33.03
36.66
30.73
28.03
42.31
Other Income
0.25
0.54
0.32
0.56
0.03
0.83
0.82
0.63
1.09
1.16
0.61
0.42
Total Income
28.23
33.11
28.08
30.67
41.18
34.62
34.25
33.66
37.75
31.89
28.64
42.73
Expenses
24.24
25.7
25.74
26.41
36.2
28.6
29.35
29.34
39.2
29.08
34.48
37.76
Operating Profit
3.75
6.86
2.03
3.7
4.96
5.2
4.08
3.69
-2.54
1.65
-6.45
4.55
Operating Profit Margin %
13.4%
21.07%
7.31%
12.29%
12.05%
15.38%
12.2%
11.17%
-6.93%
5.37%
-23.01%
10.75%
Profit Before Interest, Tax and Depreciation
3.99
7.41
2.34
4.27
4.98
6.02
4.9
4.32
-1.45
2.81
-5.84
4.97
Interest
1.19
1.28
1.07
0.65
0.54
0.61
0.47
0.85
0.79
0.82
0.7
1.01
Depreciation
3.59
2.84
2.9
1.76
1.76
1.83
1.42
2.11
2.15
2.15
2.04
2.01
Profit Before Tax
-0.79
3.29
-1.63
1.86
2.68
3.58
3.01
1.36
-4.39
-0.16
-8.58
1.95
Tax Paid
-0.18
1.27
0.46
0.57
0.76
0.87
0.99
0.36
-1.17
-0.01
-0.52
-0.1
Profit After Tax
-0.49
1.78
-2.09
1.29
1.91
2.7
2.03
1
-3.21
-0.15
-8.07
2.05
Total Net profit including share of profit / Loss from associate company
-0.49
1.78
-2.09
1.29
1.91
2.7
2.03
1
-3.21
-0.15
-8.07
2.05
EPS
-0.15
0.53
-3.83
0.4
0.58
0.75
0.49
0.25
-0.94
-
-2.1
0.57
Actual EPS
-0.15
0.53
-3.83
0.4
0.58
0.75
0.49
0.25
-0.94
-
-2.1
0.57
Adjusted EPS
-0.15
0.53
-3.83
0.4
0.58
0.75
0.49
0.25
-0.94
-
-2.1
0.57
Diluted EPS
-0.15
0.53
-3.83
0.4
0.58
0.75
0.49
0.25
-0.94
-
-2.1
0.57

Lyka Labs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
59.81
70.78
61.49
86.25
194.08
93.07
111.19
138.5
128.44
Other Income
6.16
2.09
3.09
1.56
2.09
3.4
1.45
2.23
3.5
Total Income
65.96
72.87
64.58
87.81
196.18
96.47
112.65
140.73
131.94
Expenses
63.36
73.81
98.38
67.7
99.45
83.63
95.89
120.56
132.1
Operating Profit
-3.55
-3.03
-36.89
18.55
94.63
9.44
15.3
17.94
-3.66
Operating Profit Margin %
-5.94%
-4.28%
-59.99%
21.51%
48.76%
10.14%
13.76%
12.95%
-2.85%
Profit Before Interest, Tax and Depreciation
2.61
-0.94
-33.8
20.12
96.73
12.85
16.76
20.17
-0.16
Interest
9.58
7.17
20.07
25.94
20.13
11.87
4.89
2.27
3.16
Depreciation
11.28
7.31
8.01
8.32
17.35
14.15
12.8
6.77
8.46
Profit Before Tax
-18.25
-15.42
-61.88
-14.14
59.25
-13.17
-0.93
11.13
-11.78
Tax Paid
-1.04
-9.07
0.74
-4.05
20.8
-0.02
1.69
3.2
-1.34
Profit After Tax
-17.22
-5.61
-60.54
-11.55
39
-13.21
-2.62
7.93
-10.44
Total Net profit including share of profit / Loss from associate company
-17.22
-5.61
-60.54
-11.55
39
-13.21
-2.62
7.93
-10.44
EPS
-6.71
-1.79
-21.29
-4.07
13.57
-4.63
-0.79
2.22
-2.77
Actual EPS
-6.71
-1.79
-21.29
-4.07
13.57
-4.63
-0.79
2.22
-2.77
Adjusted EPS
-6.71
-1.79
-21.29
-4.07
13.57
-4.63
-0.79
2.22
-2.77
Diluted EPS
-6.71
-1.79
-21.29
-4.07
13.57
-4.63
-0.79
2.22
-2.77

Lyka Labs Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
11.95
31.38
10.88
26.67
5.32
8.81
79.25
8.95
1.77
1.9
5.24
Cash Flow from Investing Activities
17.29
-12.67
-3.17
-3.97
-0.11
-0.16
-6.17
7.35
-9.49
-11.79
-9.41
Cash Flow from Financing Activities
-28.82
-19.15
-10.41
-23.43
3.39
-11.81
-63.18
-21.64
1.95
5.29
4.17
Net Cash Flow
-0.96
-0.43
-2.69
-0.72
8.6
-3.15
9.9
-5.34
-5.76
-4.6
0.02

Lyka Labs Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Apr 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
54.81%
54.81%
58.1%
58.1%
58.1%
58.1%
58.16%
58.16%
58.16%
58.16%
58.16%
58.45%
DII
0.41%
0.88%
0.82%
0.75%
0.67%
0.67%
0.67%
0.67%
0.67%
0.67%
0.67%
0.66%
FII
0%
0.17%
0.16%
0.15%
0.15%
0.15%
0.23%
0.16%
0.18%
0.17%
0.29%
0.17%
Public
44.4%
44.13%
40.92%
40.99%
41.08%
41.08%
40.94%
41.01%
41%
41%
40.88%
40.72%
Total Outstanding Shares
3,30,90,000
3,30,90,000
3,56,90,000
3,56,90,000
3,56,90,000
3,56,90,000
3,56,90,000
3,56,90,000
3,56,90,000
3,56,90,000
3,56,90,000
3,61,52,711
Total Shareholders
26,422
25,717
25,699
25,716
28,943
29,099
28,472
28,189
27,743
27,155
26,727
29,369

Lyka Labs Corporate Actions

View detailed summary of the earnings and dividend history of Lyka Labs.

  • Lyka Labs Ltd Earnings Results

    Lyka Labs Ltd’s net profit jumped 122.58% since last year same period to ₹2.07Cr in the Q1 2026-2027. On a quarterly growth basis, Lyka Labs Ltd has generated 127.2% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Lyka Labs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 28.64 Cr → 42.73 Cr (in ₹), with an average increase of 33.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, LYKALABS stock has moved up by 19.4%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -7.61 Cr → 2.07 Cr (in ₹), with an average increase of 467.6% per quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 58.16% to 58.45% in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 68.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.4% return, outperforming this stock by 184.7%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 40.88% to 40.72% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.29% to 0.17% in Jun 2026 quarter

About Lyka Labs Ltd

Lyka Labs, a bulk drug company, has been in the business of offering lifesaving antibiotics and treating minor infections for over three decades. Over the years, the company has also diversified into marketing medical and diagnostic machinery and equipment, ayurvedic and animal health care products, tropical steroids, anticancer products, cardiovascular drugs, and anti-inflammatory products. In the year 1991 they received a Certificate of Merit for their impressive export performance and an award from CHEMEXCIL. Two years later, their Administrative Office and Plant at Tarapur was awarded the ISO 9002 certification for its quality management system. As part of its diversification, the company had also invested in Relic Finance and acquired 26.70% of the company's paid-up equity capital through a public offer. They also launched India's first Glutathione Injection formulation during 2012-13 to become one of India's leading healthcare and pharmaceutical companies.

Revenue: ₹42.31Cr as on June 2026 (Q1 FY27)
Net Profit: ₹2.05Cr as on June 2026 (Q1 FY27)
Listing date: 08 Feb, 1995
Chairperson Name: KUNAL NARENDRA GANDHI
OrganisationLyka Labs Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOKUNAL NARENDRA GANDHI
E-voting on sharesClick here to vote

FAQs

What is Lyka Labs share price today?

Lyka Labs share price today stands at ₹79.93 as on . Lyka Labs share today touched a day high of ₹80 and a low of ₹79.93.

What is the 52 week high and 52 week low range for Lyka Labs share?

Lyka Labs touched a 52 week high of ₹101.9 and a 52 week low of ₹44.1. Lyka Labs share price today i.e. is trending at ₹79.93, which is -21.56% down from its 52 week high and 81.25% up from its 52 week low.

What is Lyka Labs's market capitalisation today?

Lyka Labs market capitalisation is ₹293.74 Cr as on .

How to buy Lyka Labs shares?

To buy Lyka Labs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for LYKALABS or Lyka Labs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Lyka Labs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Lyka Labs trading volume today?

Lyka Labs trading volume is 4,707.00 as on . This means that 4,707.00 shares of Lyka Labs were bought and sold on the stock market during today's trading session.